Funds will support development of game-changing IUD (intrauterine device) for contraception through an IND filing in early 2025 MANSFIELD, Mass., July 11, 2024 (GLOBE NEWSWIRE) — 3Daughters, Inc., a clinical development company fueling evolutionary healthcare for women, announced successful completion of an oversubscribed Seed financing round of $4.7M. This round included participation from existing investors […]
Category Archives: Pr Newswire
Pr Newswire
Palisade Bio Announces Successful Completion of First GMP Manufacturing of PALI-2108 Drug Substance and Engineering Batches of Drug Product
11
Jul
Jul
Company has now completed murine and non-murine pivotal nonclinical studies using GMP PALI-2108 drug substance Company has successfully formulated enteric-coated tablets of PALI-2108 and has demonstrated consistent and reliable drug release profiles Company on track to commence Phase 1 human clinical study of PALI-2108 for the treatment of moderate-to-severe ulcerative colitis (UC) before year end […]
11
Jul
Jul
PMI Revenues and Earnings Projected to Grow Significantly in the Second Half of 2024 and Full Year 2025. New Strategic Initiatives for PMI Create Significant Opportunities for Liquidity and Value Creation Garden City, NY, July 11, 2024 (GLOBE NEWSWIRE) — ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next-generation biotech, genomics, and diagnostics […]
Pr Newswire
Rentschler Biopharma Announces New State-of-the-Art Production Line in Massachusetts is Fully Operational
11
Jul
Jul
Largest expansion in company’s 150+-year history opens Major client project already underway; new clients actively being onboarded LAUPHEIM, Germany and MILFORD, Mass., July 11, 2024 (GLOBE NEWSWIRE) — Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, including advanced therapy medicinal products (ATMPs), today announced that the company’s new state-of-the-art […]
SHENZHEN, China, July 11, 2024 /PRNewswire/ — ZTE Corporation (0763.HK / 000063.SZ), a global leading provider of integrated information and communication technology solutions, achieved the fastest growth in global optical network market share from 2Q23 to 1Q24, according to the report Optical Networking – 1Q24 released by Omdia, a global analyst and advisory leader. This recognition […]
Pilot clinical study shows modulation of gut microbiome alleviates anxiety symptoms HONG KONG, July 11, 2024 /PRNewswire/ — A research team from The Chinese University of Hong Kong (CUHK)’s Faculty of Medicine (CU Medicine) has conducted a large cohort study among 1,627 children with and without autism spectrum disorder (ASD) and found alterations in four kingdoms […]
MANILA, Philippines, July 11, 2024 /PRNewswire/ — Sennheiser, the global leader in audio technology, is thrilled to announce the release of the highly-anticipated EW-D Series in the Philippines at their EW-D Launch event on 17 and 18 July 2024. This groundbreaking series is set to redefine professional audio standards, offering unmatched sound quality and reliability across various […]
SHENZHEN, China, July 11, 2024 /PRNewswire/ — ZTE Corporation (0763.HK / 000063.SZ), a global leading provider of integrated information and communication technology solutions, achieved the fastest growth in global optical network market share from 2Q23 to 1Q24, according to the report Optical Networking – 1Q24 released by Omdia, a global analyst and advisory leader. This recognition […]
HONG KONG, July 11, 2024 /PRNewswire/ — CNOOC Limited (the “Company”, SEHK: 00883 (HKD Counter) and 80883 (RMB Counter), SSE: 600938) announces today that the Bozhong 19-6 Condensate Gas Field D1 Well, the first ultra-deep well in Bohai Bay, achieved high yield. Bozhong 19-6 Condensate Gas Field is located in central Bohai Bay, with an […]
Pr Newswire
Crinetics Pharmaceuticals Announces July 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11
Jul
Jul
SAN DIEGO, July 10, 2024 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on July 10, 2024, the Compensation Committee of Crinetics’ Board of Directors granted non-qualified stock option awards to purchase an aggregate of 137,900 shares of its common stock to eighteen new non-executive employees under the Crinetics Pharmaceuticals, Inc. 2021 […]